Serial #79437092
LIVE

Serial Number

79437092

Owner

Sandoz AG

Filing Date

Oct 21, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79437092 Trademark

Serial Number: 79437092

Serial #79437092 is a trademark filed by Sandoz AG on October 21, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Sandoz AG (3 trademarks)

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

October 21, 2025

Registration Date

Not Registered

Goods & Services

Anti-infectives for human use; anti-inflammatories for human use; antibacterial pharmaceutical preparations for human use; antibiotics for human use; antifungal preparations for human use; antivirals for human use; cardiovascular pharmaceutical preparations for human use; dermatological pharmaceutical preparations for human use; pharmaceutical preparations for human use for inhaling for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for human use acting on the central nervous system; pharmaceutical preparations and substances for human use for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for human use, used in hematology and in tissue and organ transplantation; pharmaceutical preparations for human use for the prevention and treatment of eye diseases; pharmaceutical preparations for human use for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for human use for the prevention and treatment of diseases and disorders related to the immune system; pharmaceutical preparations for human use for the prevention and treatment of kidney diseases; pharmaceutical preparations for human use for the prevention and treatment of diabetes; pharmaceutical preparations for human use for the prevention and treatment of hypertension; pharmaceutical preparations for human use for the prevention and treatment of skin conditions; pharmaceutical preparations for human use, used in dermatology; pharmaceutical preparations for human use, used in urology; pharmaceutical preparations for human use, used in ophthalmology; pharmaceutical preparations for human use for the prevention and treatment of cancer and tumors; pharmaceutical preparations for human use for the prevention and treatment of allergies; pharmaceutical preparations for human use for the prevention and treatment of bone diseases; pharmaceutical preparations for human use for the prevention and treatment of respiratory diseases and asthma

Filing History

REFUSAL PROCESSED BY IB
May 21, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 27, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 27, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 15, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 14, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 3, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 1, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 13, 2025 SDRC